The role of surgery after chemoradiation therapy and brachytherapy for stage IB2/II cervical cancer

Gynecologic Oncology

Volumn 107, Issue 1 SUPPL., 2007, Pages

  Morice, P ^a   Uzan, C ^a   Zafrani, Y ^a   Delpech, Y ^a   Gouy, S ^a   Haie Meder, C ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Cervical cancer; Chemoradiation therapy; Completion surgery; Nodal involvement; Stage IB2 II

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; TUMOR VOLUME; UTERINE CERVIX CANCER;

ADULT; AGED; BRACHYTHERAPY; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; UTERINE CERVICAL NEOPLASMS;

EID: 34748853300     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.07.015     Document Type: Article

References (9)

1. Green J.A., Kirwan J.M., Tierney J.F., et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 358 (2001) 781-786
2. Houvenaeghel G., Lelievre L., Rigouard A.L., et al. Residual pelvic lymph node involvement after concomitant chemoradiation for locally advanced cervical cancer. Gynecol Oncol 102 (2006) 74-79
3. Houvenaeghel G., Lelievre L., Gonzague-Casabianca L., Buttarelli M., Moutardier V., Goncalves A., et al. Long-term survival after concomitant chemoradiotherapy prior to surgery in advanced cervical carcinoma. Gynecol Oncol 100 (2006) 338-343
4. Distefano M., Fagotti A., Ferrandina G., Francesco F., Smaniotto D., and Scambia G. Preoperative chemoradiotherapy in locally advanced cervical cancer: long term outcome and complications. Gynecol Oncol 99 (2005) S166-S170
5. Classe J.M., Rauch P., Rodier J.F., Morice P., et al. Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: morbidity and outcome: results of a multicenter study of the GCCLCC (Groupe des Chirurgiens de Centres de Lutte Contre le Cancer). Gynecol Oncol 102 (2006) 523-529
6. Delpech Y., Haie-Meder C., Rey A., Zafrani Y., Pautier P., Lhomme C., et al. Para-aortic involvement in stage IB 2/II cervical carcinoma confined radiologically to the pelvic cavity treated using pelvic radiotherapy and concomitant chemotherapy. 11th Meeting of International Gynecologic Cancer Society (IGCS). Int J Gynaecol Oncol Suppl. 3 (2006) 695
7. Chassagne D., Sismondi P., Horiot J.C., et al. A glossary for reporting complications of treatment in gynecological cancers. Radiother Oncol 26 (1993) 195-202
8. Azria E., Morice P., Haie-Meder C., et al. Results of hysterectomy in patients with bulky residual disease at the end of chemoradiation therapy for stage IB2/II cervical carcinoma. Ann Surg Oncol 12 (2005) 332-337
9. Rockall A.G., Sohaib S.A., Harisinghani M.G., Babar S.A., Singh N., Jeyarajah A.R., et al. Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. J Clin Oncol 23 (2005) 2813-2821